ライフサイエンスコーパス: transient ischaemic attack

1 3 patients (one minor bleeding event and one transient ischaemic attack).

2 (45,549 individuals, 2314 stroke events, 269 transient ischaemic attacks).

3 severe stroke (ie, NIHSS >10) and lowest in transient ischaemic attack.

4 patients who have had an ischaemic stroke or transient ischaemic attack.

5 rial fibrillation and a history of stroke or transient ischaemic attack.

6 thrombotic therapy after ischaemic stroke or transient ischaemic attack.

7 ed with those without a history of stroke or transient ischaemic attack.

8 ailure as an outpatient, unstable angina, or transient ischaemic attack.

9 participants without a history of stroke or transient ischaemic attack.

10 o 2) in those without a history of stroke or transient ischaemic attack.

11 uals without a previous history of stroke or transient ischaemic attack.

12 score <3), and 5.2% (3.4-7.0) in those with transient ischaemic attack.

13 ing P-selectin might aid in the diagnosis of transient ischaemic attack.

14 lial P-selectin as a potential biomarker for transient ischaemic attack.

15 o the recommended tissue-based definition of transient ischaemic attack.

16 or deficits in a rodent model mimicking true transient ischaemic attack.

17 g-based stroke risk scores in patients after transient ischaemic attack.

18 es in adults with recent ischaemic stroke or transient ischaemic attack.

19 primary endpoint was ipsilateral stroke and transient ischaemic attack.

20 minor strokes, and 2 years in those who had transient ischaemic attacks.

21 nitive impairment occurring in patients with transient ischaemic attacks.

22 tments to reduce brain damage occurring with transient ischaemic attacks.

23 indness and neurological signs that resemble transient ischaemic attacks.

24 ality (0.6% in both groups combined), stroke/transient ischaemic attack (1.4%), life-threatening blee

25 l disease (-18.5, -22.1 to -14.9), stroke or transient ischaemic attack (-16.6, -20.6 to -12.7), hype

26 tions were: completed stroke, 9 (CI: 8, 11); transient ischaemic attacks, 5 (CI: 4, 6); active epilep

27 ople with no previous diagnosis of stroke or transient ischaemic attack, 98 721 had a first ever inci

28 rticipants with previous ischaemic stroke or transient ischaemic attack, acquired baseline MRI allowi

29 ek of index transient ischaemic attack (dual transient ischaemic attack) after adjusting for ABCD2 sc

30 on criteria were stroke-specialist confirmed transient ischaemic attack, age of 18 years or older, an

31 The risk of transient ischaemic attack also seems to be increased in

32 id artery who were asymptomatic or had had a transient ischaemic attack, amaurosis fugax, or a minor

33 with a minor-to-moderate ischaemic stroke or transient ischaemic attack and a high sensitivity C-reac

34 mbolic minor-to-moderate ischaemic stroke or transient ischaemic attack and a high sensitivity C-reac

35 tivated endothelial cells after experimental transient ischaemic attack and allowed discriminating tr

36 r older, and MRI done within 7 days of index transient ischaemic attack and before stroke recurrence.

37 ardiovascular conditions (incident stroke or transient ischaemic attack and incident myocardial infar

38 All patients, irrespective of age, with transient ischaemic attack and minor ischaemic stroke oc

39 hat is known about the early prognosis after transient ischaemic attack and minor ischaemic stroke, w

40 age in predominantly Caucasian patients with transient ischaemic attack and minor ischaemic stroke.

41 n a population-based cohort of patients with transient ischaemic attack and minor stroke on intensive

42 but excess risk is substantially lower after transient ischaemic attack and minor stroke.

43 e, diabetes and peripheral vascular disease, transient ischaemic attack and stroke), atrial fibrillat

44 We ascertained changes in incidence of transient ischaemic attack and stroke, risk factors, and

45 0.006), reaching 22% for stroke and 46% for transient ischaemic attack and stroke.

46 risk factors for, dementia before and after transient ischaemic attack and stroke.

47 related this to the 90-day risk of recurrent transient ischaemic attack and stroke.

48 within the tadalafil group happened after a transient ischaemic attack and two deaths (ruptured abdo

49 ean age 74.4 years [SD 13.0]), 688 (30%) had transient ischaemic attacks and 1617 (70%) had strokes.

50 multiple fractures, respiratory failure, and transient ischaemic attack) and four events in three pat

51 nosis who are at a higher risk of stroke and transient ischaemic attack, and also those with a low ab

52 -embolic events, including ischaemic stroke, transient ischaemic attack, and systemic thromboembolism

53 we postulated that this may also be true for transient ischaemic attack, and that it would be clinica

54 s tendon) and three in the comparison group (transient ischaemic attack, and two deaths).

55 ischaemic and one haemorrhagic stroke, eight transient ischaemic attacks, and four seizures).

56 vous-system (CNS) events, including strokes, transient ischaemic attacks, and seizures are common in

57 'True' transient ischaemic attacks are characterized not only c

58 mbolism, including myocardial infarction and transient ischaemic attacks, assessed in all eligible pa

59 and basilar stenosis was associated multiple transient ischaemic attacks at presentation (22% versus

60 tory events, and is associated with multiple transient ischaemic attacks at presentation and a high e

61 ts aged 40-80 years with ischaemic stroke or transient ischaemic attack attributable to angiographica

62 , 1.18-1.78; p=0.0001), history of stroke or transient ischaemic attack before the qualifying event (

63 , 1.17-2.65; p=0.0063), history of stroke or transient ischaemic attack before the qualifying event (

64 , 98 721 had a first ever incident stroke or transient ischaemic attack between 1 January and 31 Octo

65 bsolute annual risk of ipsilateral stroke or transient ischaemic attack between baseline and 2 years

66 ronous discharges, head tremor, limb-shaking transient ischaemic attack), bobble-head doll syndrome,

67 The primary outcome was initial stroke or transient ischaemic attack, centrally adjudicated.

68 In patients with recent ischaemic stroke or transient ischaemic attack, cerebral microbleeds are ass

69 inpatients, in emergency departments, or in transient ischaemic attack clinics.

70 d chikungunya dual infection had a stroke or transient ischaemic attack, compared with five (6%) of 9

71 ast one of the following: previous stroke or transient ischaemic attack, congestive heart failure, di

72 ut vascular disease, defined as prior stroke/transient ischaemic attack, coronary or peripheral arter

73 idual-patient data from 16 cohort studies of transient ischaemic attack done in Asia, Europe, and the

74 ient ischaemic attack within 1 week of index transient ischaemic attack (dual transient ischaemic att

75 or in the ambulance in subjects suspected of transient ischaemic attack/early stroke.

76 ratio for the risk of ipsilateral stroke and transient ischaemic attack for patients who had embolic

77 -severe acute ischaemic stroke, or high-risk transient ischaemic attack from 674 hospitals in 33 coun

78 ratio for the risk of ipsilateral stroke and transient ischaemic attack from baseline to 2 years in p

79 ischaemic attack and allowed discriminating transient ischaemic attack from epilepsy and migraine, t

80 tients at highest risk of early stroke after transient ischaemic attack has been improved with imagin

81 eassessment of ABC-stroke (age, prior stroke/transient ischaemic attack, hsTnT, and NT-proBNP) and AB

82 hospitalised with acute ischaemic stroke or transient ischaemic attack, if added to usual diagnostic

83 In patients with IS or transient ischaemic attack, impaired kidney function was

84 e and male probands with ischaemic stroke or transient ischaemic attack in the population-based Oxfor

85 ate patients with recent ischaemic stroke or transient ischaemic attack in whom the rate of future in

86 adult participants with ischaemic stroke or transient ischaemic attack; included at least 50 partici

87 Failure to diagnose transient ischaemic attack is a wasted opportunity to pr

88 effective, and rapid diagnosis of stroke and transient ischaemic attack is crucial.

89 -based cohort study in patients with a first transient ischaemic attack, ischaemic stroke, or myocard

90 During a transient ischaemic attack it is assumed that the affect

91 rial fibrillation and a history of stroke or transient ischaemic attack led to a 7% absolute risk red

92 Transient ischaemic attack management guided by ABCD3-I

93 ck from epilepsy and migraine, two important transient ischaemic attack mimics.

94 mpairment that characterize this rodent true transient ischaemic attack model.

95 participants without a history of stroke or transient ischaemic attack (n=3666; 1843 assigned to api

96 Major outcome events were transient ischaemic attack, non-disabling, disabling, an

97 A fifth of all strokes and transient ischaemic attacks occur in the posterior circu

98 A transient ischaemic attack occurred in the high-dose ind

99 t of ipsilateral non-perioperative stroke or transient ischaemic attack occurred more often in patien

100 ewers, no strokes were identified, but three transient ischaemic attacks occurred in each group.

101 sation for a symptomatic ipsilateral stroke, transient ischaemic attack or amaurosis fugax) as potent

102 eykjavik study who had no history of stroke, transient ischaemic attack or dementia (n = 668, 378 fem

103 should be considered for most patients with transient ischaemic attack or ischaemic stroke in the ac

104 grouping together all people who have had a transient ischaemic attack or minor ischaemic stroke (in

105 s with a recent (within the previous 7 days) transient ischaemic attack or minor ischaemic stroke (mo

106 5-year functional outcomes in patients with transient ischaemic attack or minor ischaemic stroke and

107 ive, observational registry of patients with transient ischaemic attack or minor ischaemic stroke fro

108 f age, presenting with posterior circulation transient ischaemic attack or minor ischaemic stroke in

109 jor vascular events in people who have had a transient ischaemic attack or minor ischaemic stroke, re

110 In patients with transient ischaemic attack or minor ischaemic stroke, th

111 isability (mRS score of >1) at 5 years after transient ischaemic attack or minor ischemic stroke, and

112 ion worldwide in how patients with suspected transient ischaemic attack or minor stroke are investiga

113 Patients who have had a transient ischaemic attack or minor stroke have an incre

114 nd basilar stenosis in posterior circulation transient ischaemic attack or minor stroke is greater th

115 ent stroke during the first few days after a transient ischaemic attack or minor stroke is much highe

116 recurrent stroke after posterior circulation transient ischaemic attack or minor stroke versus after

117 Patients aged 18 years or older who had a transient ischaemic attack or minor stroke within the pr

118 ata for risk of dementia, particularly after transient ischaemic attack or minor stroke, are scarce.

119 No patient reported symptoms of a transient ischaemic attack or stroke during or within 24

120 Patients with transient ischaemic attack or stroke occurring between A

121 rmuted block sizes) 451 patients with recent transient ischaemic attack or stroke related to 70-99% s

122 dence of dementia in patients who have had a transient ischaemic attack or stroke varies substantiall

123 l patients in OxVasc with a recent suspected transient ischaemic attack or stroke, between April 1, 2

124 Of 476 patients with transient ischaemic attacks or strokes in OXVASC, 262 st

125 (odds ratio [OR] 3.8, 95% CI 2.1-7.0), dual transient ischaemic attack (OR 3.3, 95% CI 1.8-5.8), and

126 a cerebral ischaemic event (either stroke or transient ischaemic attack) or a further ICH following s

127 CV endpoint of myocardial infarction, stroke/transient ischaemic attack, or coronary revascularizatio

128 es if they had a previous history of stroke, transient ischaemic attack, or ischaemic heart disease a

129 ization), cerebrovascular (ischaemic stroke, transient ischaemic attack, or urgent cerebral revascula

130 ere associated with 7 day stroke after index transient ischaemic attack (p<0.001 for all).

131 microbleeds can identify ischaemic stroke or transient ischaemic attack patients at higher absolute r

132 tensive rats, a strain representative of the transient ischaemic attack-prone population.

133 Amongst subjects with stroke/transient ischaemic attack, smoking at the time of the e

134 dy of 1490 patients with ischaemic stroke or transient ischaemic attack (TIA) and AF treated with OAC

135 ations (n=950) from a study of occurrence of transient ischaemic attack (TIA) and ischaemic stroke an

136 (separately for haemorrhagic and ischaemic), transient ischaemic attack (TIA) and subarachnoid haemor

137 nostic scores for early risk of stroke after transient ischaemic attack (TIA) and to derive and valid

138 elet therapy did not reduce recurrent stroke/transient ischaemic attack (TIA) events as compared with

139 Patients with AF and previous stroke or transient ischaemic attack (TIA) have a high risk of str

140 reports in Caucasians and Asians with stroke/transient ischaemic attack (TIA) have suggested lower IC

141 Transient ischaemic attack (TIA) is increasingly recogni

142 post-stroke fatigue in patients with a young transient ischaemic attack (TIA) or ischaemic stroke and

143 s recommended for secondary prevention after transient ischaemic attack (TIA) or ischaemic stroke on

144 Patients with transient ischaemic attack (TIA) or minor stroke are at

145 assessment and treatment after the onset of transient ischaemic attack (TIA) or minor stroke.

146 rent stroke is up to 10% in the week after a transient ischaemic attack (TIA) or minor stroke.

147 of association was greatest with a previous transient ischaemic attack (TIA) or stroke and chronic k

148 ase, in a patient cohort of ischaemic stroke/transient ischaemic attack (TIA) referrals.

149 , patients with a recent ischaemic stroke or transient ischaemic attack (TIA) were randomised to piog

150 Patients with suspected transient ischaemic attack (TIA) with no symptoms or sig

151 adult participants with ischaemic stroke or transient ischaemic attack (TIA) within 48 h of onset.

152 Patients with first-ever stroke/transient ischaemic attack (TIA), >/=18 y, with diagnosi

153 Stroke is often preceded by transient ischaemic attack (TIA), but studies of stroke

154 tively prevents early recurrent stroke after transient ischaemic attack (TIA), but this approach may

155 ts were followed prospectively until stroke, transient ischaemic attack (TIA), death or study end.

156 tries provided data on CVD including stroke, transient ischaemic attack (TIA), or coronary heart even

157 in patients with recent ischaemic stroke or transient ischaemic attack (TIA).

158 ngs, but there are few data in patients with transient ischaemic attack (TIA)/stroke.

159 mum blood pressure in patients with previous transient ischaemic attack (TIA; UK-TIA trial and three

160 Transient ischaemic attacks (TIA) are more than just min

161 Effective early management of patients with transient ischaemic attacks (TIA) is undermined by an in

162 : 918 (45%) cerebrovascular (618 stroke, 300 transient ischaemic attacks [TIA]); 856 (42%) coronary v

163 diplopia) are not consistently classified as transient ischaemic attacks (TIAs) and data for prognosi

164 A third of transient ischaemic attacks (TIAs) and ischaemic strokes

165 Vertebrobasilar (VB) territory transient ischaemic attacks (TIAs) and minor strokes are

166 Diagnosis of transient ischaemic attacks (TIAs) can be difficult.

167 bosis was associated with increased rates of transient ischaemic attacks (TIAs; 4.18 TIAs per 100 per

168 analysis of patients in the Acute Stroke or Transient Ischaemic Attack Treated with Aspirin or Ticag

169 0.81-1.31, p=0.8), but the hazard ratio for transient ischaemic attack was 0.75 (0.55-1.00, p=0.051)

170 in participants with a history of stroke or transient ischaemic attack was 2.26% with apixaban (n=13

171 A history of stroke or transient ischaemic attack was present in 346 (8.6%) par

172 -cardioembolic ischaemic stroke or high-risk transient ischaemic attack were eligible.

173 cks or strokes in OXVASC, 262 strokes and 93 transient ischaemic attacks were incident events.

174 s in patients with acute ischaemic stroke or transient ischaemic attack when associated with ipsilate

175 ients with ischaemic stroke have a preceding transient ischaemic attack, which is clinically defined

176 rial fibrillation and a history of stroke or transient ischaemic attack, who are known to have an inc

177 k patients at highest risk of a stroke after transient ischaemic attack with improved risk prediction

178 iffusion-weighted MRI, carotid stenosis, and transient ischaemic attack within 1 week of index transi

179 who were asymptomatic or had had a stroke or transient ischaemic attack within 180 days before random

180 east 18 years with acute ischaemic stroke or transient ischaemic attack without known atrial fibrilla